MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway

IUBMB Life

Volumn 67, Issue 10, 2015, Pages 768-777

  Li, Shou Qing ^a   Wang, Zi Hang ^c   Mi, Xu Guang ^b   Liu, Lei ^b   Tan, Yan ^a,b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Jilin Province People's Hospital   (China)

^c YANBIAN UNIVERSITY   (China)

Author keywords

breast cancer; cancer metastasis; miR 199a b 3p; PAK4

Indexed keywords

MICRORNA; MICRORNA 199A B 3P; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE 4; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MIRN199 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; P21 ACTIVATED KINASE; PAK4 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST METASTASIS; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MCF 7 CELL LINE; SIGNAL TRANSDUCTION; 3' UNTRANSLATED REGION; BINDING SITE; BREAST TUMOR; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; P21-ACTIVATED KINASES; RNA INTERFERENCE;

EID: 84944883219     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1433     Document Type: Article

References (30)

1. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., et al., (2015) Global cancer statistics, 2012. CA Cancer J Clin. 65, 87-108.
2. Yates, L. A., Norbury, C. J., and, Gilbert, R. J., (2013) The long and short of microRNA. Cell 153, 516-519.
3. Acunzo, M., Romano, G., Wernicke, D., and, Croce, C. M., (2015) MicroRNA and cancer-a brief overview. Adv. Biol. Regul. 57, 1-9.
4. Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A., and, Tuschl, T., (2003) New microRNAs from mouse and human. RNA 9, 175-179.
5. Lim, L. P., Lau, N. C., Weinstein, E. G., Abdelhakim, A., Yekta, S., et al., (2003) The microRNAs of Caenorhabditis elegans. Genes Dev. 17, 991-1008.
6. Hou, J., Lin, L., Zhou, W., Wang, Z., Ding, G., et al., (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell. 19, 232-243.
7. Roderburg, C., Trautwein, C., and, Luedde, T., (2011) MicroRNA-199a/b-3p: a new star in the liver microcosmos. Hepatology 54, 729-731.
8. Duan, Q., Wang, X., Gong, W., Ni, L., Chen, C., et al., (2012) ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One 7, e31518
9. Wang, Z., Ting, Z., Li, Y., Chen, G., Lu, Y., et al., (2013) microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin. Oncol. Lett. 6, 789-794.
10. Tsukigi, M., Bilim, V., Yuuki, K., Ugolkov, A., Naito, S., et al., (2012) Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3beta. Cancer Lett. 315, 189-197.
11. Duan, Z., Choy, E., Harmon, D., Liu, X., Susa, M., et al., (2011) MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol. Cancer Ther. 10, 1337-1345.
12. Minna, E., Romeo, P., De Cecco, L., Dugo, M., Cassinelli, G., et al., (2014) miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma. Oncotarget 5, 2513-2528.
13. Wu, D., Huang, H. J., He, C. N., and, Wang, K. Y., (2013) MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR). Int. J. Gynecol. Cancer 23, 1191-1197.
14. Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S. F., et al., (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 8, R214
15. Peng, W., Chen, Z. Y., Wang, L., Wang, Z., and, Li, J., (2013) MicroRNA-199a-3p is downregulated in gastric carcinomas and modulates cell proliferation. Genet. Mol. Res. 12, 3038-3047.
16. Zhang, J., Wu, G. Q., Zhang, Y., Feng, Z. Y., and, Zhu, S. M., (2013) Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression. Cell Biol. Int. 37, 227-232.
17. Zhang, J., Zhang, D., Wu, G. Q., Feng, Z. Y., and, Zhu, S. M., (2013) Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. Hepatobiliary Pancreat Dis. Int. 12, 305-309.
18. Tian, Y., Zhang, Y. Z., and, Chen, W., (2014) MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells. Biosci. Rep. 34
19. Shen, L., Sun, C., Li, Y., Li, X., Sun, T., et al., MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway. Tumour Biol., in press.
20. Mi, X. G., Song, Z. B., Wu, P., Zhang, Y. W., Sun, L. G., et al., (2014) Alantolactone induces cell apoptosis partially through down-regulation of testes-specific protease 50 expression. Toxicol. Lett. 224, 349-355.
21. Wang, F., Zheng, Z., Guo, J., and, Ding, X., (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol. Oncol. 119, 586-593.
22. Liu, Y., Xiao, H., Tian, Y., Nekrasova, T., Hao, X., et al., (2008) The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol. Cancer Res. 6, 1215-1224.
23. Mak, G. W., Chan, M. M., Leong, V. Y., Lee, J. M., Yau, T. O., et al., (2011) Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis. Cancer Res. 71, 2949-2958.
24. Wells, C. M., Whale, A. D., Parsons, M., Masters, J. R., and, Jones, G. E., (2010) PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J. Cell Sci. 123, 1663-1673.
25. Kesanakurti, D., Chetty, C., Rajasekhar Maddirela, D., Gujrati, M., and, Rao, J. S., (2012) Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis. 3, e445
26. Tabusa, H., Brooks, T., and, Massey, A. J., (2013) Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling. Mol. Cancer Res. 11, 109-121.
27. Tyagi, N., Bhardwaj, A., Singh, A. P., McClellan, S., Carter, J. E., et al., (2014) p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-kappaB pathway. Oncotarget 5, 8778-8789.
28. Zhang, L., Lyer, A. K., Yang, X., Kobayashi, E., Guo, Y., et al., (2015) Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells. Int. J. Nanomed. 10, 2913-2924.
29. Zhang, H. J., Siu, M. K., Yeung, M. C., Jiang, L. L., Mak, V. C., et al., (2011) Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Carcinogenesis 32, 765-771.
30. Bompard, G., Rabeharivelo, G., Cau, J., Abrieu, A., Delsert, C., et al., (2013) P21-activated kinase 4 (PAK4) is required for metaphase spindle positioning and anchoring. Oncogene 32, 910-919.